@article{article, title  = {{Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)}},

 publisher = {{Ovid Technologies (Wolters Kluwer Health)}},

 url = {{}},

 year = {{2022}},

 month = {{7}},

 author = {{Lee MMY and Gillis KA and Brooksbank KJM and Allwood-Spiers S and Hall Barrientos P and Wetherall K and Roditi G and AlHummiany B and Berry C and Campbell RT and Chong V et al}},

 doi = {{10.1161/circulationaha.122.059851}},

 volume = {{146}},

 journal = {{Circulation}},

 issue = {{4}},

 pages = {{364-367}},

 note = {{Accessed on 2024/12/22}}}